Translational Development Acquisition (TDACW) Income from Continuing Operations (2024 - 2026)
Translational Development Acquisition (TDACW) reported Income from Continuing Operations of 1332797.0 for Q1 2026, down 10.13% on a YoY basis from 1483074.0 in Q1 2025, and down 9.37% quarter-over-quarter from 1470543.0 in Q4 2025.
Translational Development Acquisition (TDACW) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Translational Development Acquisition has reported Income from Continuing Operations for 3 years, with the latest figure at 1332797.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 10.13% year-over-year to 1332797.0; the trailing twelve-month figure through Mar 2026 stood at 6086804.0 (up 331.06% YoY), and the FY2025 full-year result was 6362427.0, up 9059.65% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1332797.0, down from 1470543.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1660122.0 in Q3 2025, with the low at 61283.0 in Q3 2024.
- Historically, Income from Continuing Operations has averaged 937358.25 across 3 years, with a median of 1401670.0 in 2025.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations surged 96440.77% — and 2026, when it dropped 10.13%.
- Translational Development Acquisition's Income from Continuing Operations stood at 8044.0 in 2024, then surged by 18381.24% to 1470543.0 in 2025, then fell by 9.37% to 1332797.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1332797.0 (Q1 2026), 1470543.0 (Q4 2025), and 1660122.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 3.87 Mn |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 2.22 Mn |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 2.52 Mn |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 2.89 Mn |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 1.49 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 2.75 Mn |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 2.17 Mn |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 2.95 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 1.70 Mn |
| 10 | Translational Development Acquisition | - | - | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | -8,044.00 |
| Sep 30, 2024 | -61,283.00 |
| Jun 30, 2024 | -1,685.00 |